Tags

Type your tag names separated by a space and hit enter

Psoriasis

Psoriasis is a topic covered in the 5-Minute Clinical Consult.

To view the entire topic, please or purchase a subscription.

Medicine Central™ is a quick-consult mobile and web resource that includes diagnosis, treatment, medications, and follow-up information on over 700 diseases and disorders, providing fast answers—anytime, anywhere. Explore these free sample topics:

Medicine Central

-- The first section of this topic is shown below --

Basics

Description

  • A chronic, inflammatory disorder most commonly characterized by cutaneous erythematous plaques with silvery scale. It is a complex immune-mediated disorder that results from a polygenic predisposition in the setting of environmental triggers. It is associated with flares related to systemic, psychological, infectious, and environmental factors; skin disease with multiple different phenotypic variations and degrees of severity
  • Clinical phenotypes
    • Plaque (vulgaris): most common variant (~80% of cases); well-demarcated, red plaques with thick, silvery scale; symmetrically distributed most commonly on the scalp, extensor surfaces of extremities, and trunk
    • Guttate: <2% of psoriasis patients, usually in patients <30 years of age; presents abruptly with 1- to 10-mm droplet-shaped pink erythematous papules with fine scale over trunk and extremities; often preceded by group A β-hemolytic streptococcal infection 2 to 3 weeks prior
    • Inverse: affects intertriginous areas and flexural surfaces; pink-to-red plaques with minimal scale; absence of satellite pustules distinguishes it from candidiasis although may coexist.
    • Erythrodermic: generalized erythema and scaling, affecting 90% of body surface area (BSA) or more; associated with desquamation; hair loss; nail dystrophy; and systemic symptoms such as fever, chills, malaise, lymphadenopathy, and/or high-output cardiac failure; usually requires hospital admission for management of dehydration, electrolyte abnormalities, and risk of infection
    • Pustular: sterile pustules; several forms including generalized pustular psoriasis, localized pustular psoriasis, and impetigo herpetiformis (in pregnancy); generalized type can result in life-threatening bacterial superinfections, sepsis, and dehydration if left untreated.
    • Nail disease: pitting, oil spots, and onycholysis; nails involved in up to 50% of patients with psoriasis with lifetime incidence of 80–90%; increased association with psoriatic arthritis
    • Psoriatic arthritis: 5–30% of patients; most commonly asymmetrical oligoarthritis involving the hands and feet

Epidemiology

Incidence
Predominant sex: male = female; predominant age: two peaks of incidence between the ages of 20 to 30 years and 50 to 60 years

Prevalence
  • 2–4%—similar prevalence in all races
  • Estimated 125 million affected worldwide (1)

Etiology and Pathophysiology

Psoriasis is a complex immune-mediated disorder with interactions between dendritic cells, T lymphocytes, neutrophils, and keratinocytes. It is considered a TH1- and TH17-driven disease with numerous cytokines including TNF-α, interferon-γ, IL-12, IL-17, and IL-23 playing pathogenic roles resulting in an inflammatory, hyperproliferative state.

Genetics
  • Genetic predisposition (polygenic)
  • 40% have psoriasis in a first-degree relative.
  • Multiple susceptibility loci contain genes involved in immune system regulation (e.g., psoriasis susceptibility [PSORS1] locus on chromosome 6p21; polymorphisms in the IL-12/IL-13 receptor, the p40 subunit of IL-12 and IL-23, and the p19 subunit of IL-12) (2).
  • HLA-Cw6 is most strongly correlated with early onset psoriasis.

Risk Factors

  • Family history
  • Obesity (may contribute to more severe disease)
  • Local trauma; local irritation (Koebner phenomenon)
  • HIV
  • Streptococcal infection
  • Mental stress (exacerbation)
  • Medications (lithium, antimalarials, β-blockers, interferon, TNF-α inhibitors, withdrawal of steroids)
  • Smoking
  • Alcohol

General Prevention

Avoid triggers, including trauma, sunburns, smoking, and exposure to certain medications (as mentioned earlier), alcohol, and stress; weight loss if obese

Commonly Associated Conditions

  • Psoriatic arthritis
  • Seborrheic dermatitis
  • Obesity, metabolic syndrome, diabetes, chronic kidney disease
  • Cardiovascular disease; atherosclerotic disease
  • Nonalcoholic fatty liver disease (NAFLD)
  • Autoimmune: Crohn disease, ankylosing spondylitis
  • Psychiatric/psychological: depression, suicide, emotional burden/anxiety, alcohol abuse

-- To view the remaining sections of this topic, please or purchase a subscription --

Citation

Stephens, Mark B., et al., editors. "Psoriasis." 5-Minute Clinical Consult, 27th ed., Wolters Kluwer, 2019. Medicine Central, im.unboundmedicine.com/medicine/view/5-Minute-Clinical-Consult/116501/all/Psoriasis.
Psoriasis. In: Stephens MB, Golding J, Baldor RA, et al, eds. 5-Minute Clinical Consult. 27th ed. Wolters Kluwer; 2019. https://im.unboundmedicine.com/medicine/view/5-Minute-Clinical-Consult/116501/all/Psoriasis. Accessed August 19, 2019.
Psoriasis. (2019). In Stephens, M. B., Golding, J., Baldor, R. A., & Domino, F. J. (Eds.), 5-Minute Clinical Consult. Available from https://im.unboundmedicine.com/medicine/view/5-Minute-Clinical-Consult/116501/all/Psoriasis
Psoriasis [Internet]. In: Stephens MB, Golding J, Baldor RA, Domino FJ, editors. 5-Minute Clinical Consult. Wolters Kluwer; 2019. [cited 2019 August 19]. Available from: https://im.unboundmedicine.com/medicine/view/5-Minute-Clinical-Consult/116501/all/Psoriasis.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC T1 - Psoriasis ID - 116501 ED - Stephens,Mark B, ED - Golding,Jeremy, ED - Baldor,Robert A, ED - Domino,Frank J, BT - 5-Minute Clinical Consult, Updating UR - https://im.unboundmedicine.com/medicine/view/5-Minute-Clinical-Consult/116501/all/Psoriasis PB - Wolters Kluwer ET - 27 DB - Medicine Central DP - Unbound Medicine ER -